Researchers examined the heritability of body mass index (BMI), highlighting that genetics and the gut microbiome both play major roles in obesity risk. The review emphasizes that maternal microbiome ...

Obesity is a condition characterized by excessive accumulation of body fat, a growing concern in both the canine and feline ...

The authors of a recent Lancet report argue that obesity should not just be seen as a risk factor for other diseases — but in some cases, should be seen as a disease itself. The position could change ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

MÁLAGA, Spain — An online obesity clinic named Embla was associated ... according to new real-world data. Average weight loss reached 16.7% after 64 weeks’ use of the digital health platform ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

Key research pitching the drugs against each other found Mounjaro was superior when it came to shedding pounds and losing ...

A new study suggests that weight-loss drugs may significantly reduce alcohol consumption in people with obesity.

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...